Ocriplasmin: who is the best candidate?

Ocriplasmin: who is the best candidate?

Claudia M Prospero Ponce, William Stevenson, Rachel Gelman, Daniel R Agarwal, John B Christoforidis Retina Division, Department of Ophthalmology, University of Arizona Medical Center, Tucson, AZ, USA Abstract: Enzymatic vitreolysis is currently the focus of attention around the world for treating...

Full description

Bibliographic Details
Main Authors:	Prospero Ponce CM, Stevenson W, Gelman R, Agarwal DR, Christoforidis JB
Format:	Article
Language:	English
Published:	Dove Medical Press 2016-03-01
Series:	Clinical Ophthalmology
Subjects:	Vitreomacular traction Macular Hole Enzymatic vitreolysis Ocriplasmin-Best candidate Diabetic macular edema future management
Online Access:	https://www.dovepress.com/ocriplasmin-who-is-the-best-candidate-peer-reviewed-article-OPTH

Similar Items

Incomplete Vitreomacular Traction Release Using Intravitreal Ocriplasmin
by: Eric K. Chin, et al.
Published: (2014-12-01)

Effect of Funding Source on “Spin” in Studies of Ocriplasmin Therapy for Vitreomacular Traction and Macular Hole
by: Hubschman S, et al.
Published: (2020-01-01)

[Cost-effectiveness analysis of ocriplasmin in the treatment of vitreomacular traction in Italy]
by: Lucia Sara D'Angiolella, et al.
Published: (2015-12-01)

Six months follow up of a single intravitreal injection of ocriplasmin for symptomatic vitreomacular adhesion
by: Fernanda Pacella, et al.
Published: (2016-03-01)

Pneumatic vitreolysis versus vitrectomy for the treatment of vitreomacular traction syndrome and macular holes: complication analysis and systematic review with meta-analysis of functional outcomes
by: Miguel A. Quiroz-Reyes, et al.
Published: (2023-05-01)

Myopic macular hole detachment associated with intravitreal ocriplasmin
by: Li Yen Goh, et al.
Published: (2020-09-01)

Prognostic Factors Associated with Ocriplasmin Efficacy for the Treatment of Symptomatic Vitreomacular Adhesion and Full-thickness Macular Hole: Analysis from Four Studies
by: Brian C. Joondeph, et al.
Published: (2021-01-01)

Clinical characteristics and selection of treatment modality for patients with vitreomacular traction: real-world implementation of NICE guidance (TA297)
by: Pritchard EWJ, et al.
Published: (2016-01-01)

Pneumatic vitreolysis for management of symptomatic focal vitreomacular traction
by: Clement K Chan, et al.
Published: (2017-01-01)

Multimodal imaging of macular subretinal deposits following intravitreal ocriplasmin injection
by: Nicholas Chow, et al.
Published: (2018-03-01)

Efficacy and Safety of Ocriplasmin Use for Vitreomacular Adhesion and Its Predictive Factors: A Systematic Review and Meta-Analysis
by: Xi Chen, et al.
Published: (2022-01-01)

Ocriplasmin in the Treatment of Vitreomacular Traction in a Patient with Central Retinal Vein Occlusion: A Case Report
by: Alessandra Rosati, et al.
Published: (2018-07-01)

Visual functional changes after ocriplasmin injection for vitreomacular traction: A microperimetric analysis
by: Claudio Furino, et al.
Published: (2021-01-01)

Retrospective Study of Ellipsoid Zone Integrity Following Treatment with Intravitreal Ocriplasmin (OZONE Study)
by: Drenser KA, et al.
Published: (2021-07-01)

Spontaneous Resolution of Vitreomacular Traction in Two Patients with Diabetic Macular Edema
by: David R.P. Almeida, et al.
Published: (2014-02-01)

Pneumatic Vitreolysis for the Treatment of Vitreomacular Traction Syndrome
by: Hüseyin Baran Özdemir, et al.
Published: (2019-08-01)

VITREOMACULAR INTERFACE PATHOLOGY. REVIEW OF FOREIGN LITERATURE IN QUESTIONS AND ANSWERS
by: L. I. Balashevich, et al.
Published: (2015-10-01)

Assessment of E. coli Expression System for Overexpression of Active Recombinant Ocriplasmin
by: Roghayyeh Baghban, et al.
Published: (2021-06-01)

Patient-reported outcomes of ocriplasmin for the treatment of vitreomacular traction: a systematic review and synthesis of the literature
by: Lescrauwaet B, et al.
Published: (2019-03-01)

Reduced perfusion density of superficial retinal capillary plexus after intravitreal ocriplasmin injection for idiopathic vitreomacular traction
by: Lorenzo Iuliano, et al.
Published: (2019-05-01)

Idiopathic Macular Hole: Algorithm for Nonsurgical Closure Based on Literature Review
by: Ahmad M Mansour, et al.
Published: (2023-11-01)

Results of vitreomacular tractionnon-surgical treatment using bacterial collagenase
by: P. V. Lyskin, et al.
Published: (2019-11-01)

Prevalence of vitreomacular adhesion: an optical coherence tomography analysis in the retina clinic setting
by: Reichel E, et al.
Published: (2016-04-01)

Postvitrectomy macular hole undergoing delayed closure after 28 months
by: Rutul Patel, et al.
Published: (2017-01-01)

Intravitreal Bevacizumab May Increase Diabetic Macular Edema in Eyes with Attached Posterior Vitreous
by: Mustafa Ozsutcu, et al.
Published: (2013-01-01)

Early macular changes after phacoemulsification in eyes with high myopia
by: Hossein Ashraf, et al.
Published: (2018-01-01)

Features in dynamics of macular pigment status and central retinal sensitivity in vitreoretinal surgery for diabetic macular edema
by: M. M. Bikbov, et al.
Published: (2018-04-01)

Spontaneous Closure of a Full-Thickness Macular Hole Associated with Proliferative Diabetic Retinopathy and Persistent Vitreomacular Traction
by: Benjamin J. Reinherz, et al.
Published: (2016-03-01)

Short-Term Results of Ocriplasmin versus Prompt Vitrectomy for Macular Hole. Which Performs Better?
by: Andrea Cacciamani, et al.
Published: (2020-12-01)

A case report of cystoid macular edema, uveitis and vitreomacular traction in a patient taking Anastrozole
by: Kevin H. Nguyen, et al.
Published: (2022-03-01)

Photoreceptor Outer Segment on Internal Limiting Membrane after Macular Hole Surgery: Implications for Pathogenesis
by: Michael E. Grinton, et al.
Published: (2015-09-01)

OCT proves that vitreomacular adhesion is significantly more likely to develop vision-threatening retinal complications than vitreomacular separation
by: Ding-Ying Liao, et al.
Published: (2020-04-01)

Effect of pneumatic vitreolysis in management of patients with symptomatic focal vitreomacular traction
by: Ahmed N. Fouad, et al.
Published: (2022-03-01)

Vitreoretinal interface abnormalities in diabetic macular edema and effectiveness of anti-VEGF therapy: an optical coherence tomography study
by: Kulikov AN, et al.
Published: (2017-11-01)

Role of Tractional Forces and Internal Limiting Membrane in Macular Hole Formation: Insights from Intraoperative Optical Coherence Tomography
by: Elad Moisseiev, et al.
Published: (2016-07-01)

Acute transient macular detachment after uneventful cataract surgery in a highly myopic eye
by: Tommaso Verdina, et al.
Published: (2021-06-01)

Evaluating the effect of Perfluoropropane assisted pneumatic vitreolysis in cases of symptomatic focal vitreomacular traction
by: Osama R Elnaggar, et al.
Published: (2023-01-01)

Surgical technique to avoid deroofing in advanced vitreomacular traction
by: Prabhushanker Mahalingam, et al.
Published: (2015-01-01)

Pharmacologic Vitreolysis
by: Hossein Nazari, et al.
Published: (2010-01-01)

Vitreomacular Traction Syndrome
by: Juliana Bottós, et al.
Published: (2012-01-01)